納布啡在日間手術預防性多模式鎮痛中的優勢_West China Medical Journal

Authors：

鄧超奕 , 朱倩梅 ,  王曉

四川大學華西醫院麻醉科（成都 610041）;

Corresponding?author：

王曉, Email: wangxiao2010111@qq.com

Keywords：

納布啡; 日間手術; 鎮痛; 呼吸抑制

DOI：

10.7507/1002-0179.201611041

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

納布啡作為阿片受體激動-拮抗劑，主要激動 κ 受體，拮抗 μ 受體，減輕了對心血管及呼吸的抑制作用，更好地發揮了鎮靜、鎮痛的作用。同時納布啡的起效時間快，持續時間長，與其他激動 μ 受體阿片類藥物相比，納布啡的不良反應較少，甚至可拮抗 μ 受體相關的副作用。該文通過回顧納布啡的機制特點、藥理作用，以及近些年來它在國內外日間手術麻醉中的應用，希望為實施日間手術麻醉提供一個新的思路。

Citation： 鄧超奕, 朱倩梅, 王曉. 納布啡在日間手術預防性多模式鎮痛中的優勢. West China Medical Journal, 2017, 32(11): 1797-1800. doi: 10.7507/1002-0179.201611041 Copy

1.	Miller RD, Cohen NH, Eriksson LI, et al. Miller’s anesthesia. 8th ed. Philadelphia: Elsevier Saunders, 2015: 1050-1051.
2.	Beaver WT, Feise GA. A comparison of the analgesic effect of intramuscular nalbuphine and morphine in patients with postoperative pain. J Pharmacol Exp Ther, 1978, 204(2): 487-496.
3.	Klepper ID, Rosen M, Vickers MD, et al. Respiratory function following nalbuphine and morphine in anaesthetized man. Br J Anaesth, 1986, 58(6): 625-629.
4.	Parker RK, Holtmann B, White PF. Patient-controlled epidural analgesia: interactions between nalbuphine and hydromorphone. Anesth Analg, 1997, 84(4): 757-763.
5.	Yeh YC, Lin TF, Lin FS, et al. Combination of opioid agonist and agonist-antagonist: patient-controlled analgesia requirement and adverse events among different-ratio morphine and nalbuphine admixtures for postoperative pain. Br J Anaesth, 2008, 101(4): 542-548.
6.	Errick JK, Heel RC. Nalbuphine. A preliminary review of its pharmacological properties and therapeutic efficacy. Drugs, 1983, 26(3): 191-211.
7.	Zola EM, Mcleod DC. Comparative effects and analgesic efficacy of the agonist-antagonist opioids. Drug Intell Clin Pharm, 1983, 17(6): 411-417.
8.	Riviere PJ. Peripheral kappa-opioid agonists for visceral pain. Br J Pharmacol, 2004, 141(8): 1331-1334.
9.	Narver HL. Nalbuphine, a non-controlled opioid analgesic, and its potential use in research mice. Lab Anim (NY), 2015, 44(3): 106-110.
10.	Graham JL, McCaughey W, Bell PF. Nalbuphine and pentazocine in an opioid-benzodiazepine sedative technique: a double-blind comparison. Ann R Coll Surg Engl, 1988, 70(4): 200-204.
11.	Sury MR, Cole PV. Nalbuphine combined with midazolam for outpatient sedation. An assessment of safety in volunteers. Anaesthesia, 1988, 43(4): 281-284.
12.	Romagnoli A, Keats AS. Ceiling effect for respiratory depression by nalbuphine. Clin Pharmacol Ther, 1980, 27(4): 478-485.
13.	Gal TJ, DiFazio CA, Moscicki J. Analgesic and respiratory depressant activity of nalbuphine: a comparison with morphine. Anesthesiology, 1982, 57(5): 367-374.
14.	Bressolle F, Khier S, Rochette A, et al. Population pharmacokinetics of nalbuphine after surgery in children. Br J Anaesth, 2011, 106(4): 558-565.
15.	Lee G, Low RI, Amsterdam EA, et al. Hemodynamic effects of morphine and nalbuphine in acute myocardial infarction. Clin Pharmacol Ther, 1981, 29(5): 576-581.
16.	Lake CL, Duckworth EN, DiFazio CA, et al. Cardiovascular effects of nalbuphine in patients with coronary or valvular heart disease. Anesthesiology, 1982, 57(6): 498-503.
17.	Zhang SZ, Wang NF, Xu J, et al. Kappa-opioid receptors mediate cardioprotection by remote preconditioning. Anesthesiology, 2006, 105(3): 550-556.
18.	Zhang Y, Irwin MG, Wong TM, et al. Remifentanil preconditioning confers cardioprotection via cardiac kappa- and delta-opioid receptors. Anesthesiology, 2005, 102(2): 371-378.
19.	Zsigmond EK, Winnie AP, Raza SM, et al. Nalbuphine as an analgesic component in balanced anesthesia for cardiac surgery. Anesth Analg, 1987, 66(11): 1155-1164.
20.	Chawda PM, Pareek MK, Mehta KD. Effect of nalbuphine on haemodynamic response to orotracheal intubation. J Anaesthesiol Clin Pharmacol, 2010, 26(4): 458-460.
21.	Fating DR, Dandekar AK, Tirpude NG. Role of IV nalbuphine in attenuation of haemodynamic response to laryngoscopy and endotracheal intubation. Indian J Clin Anaesth, 2016, 3(2): 165-169.
22.	Gan TJ, Habib AS, Miller TE, et al. Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US National survey. Curr Med Res Opin, 2014, 30(1): 149-160.
23.	Vanderah TW, Suenaga NM, Ossipov MH, et al. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci, 2001, 21(1): 279-286.
24.	Joshi GP, Ogunnaike BO. Consequences of inadequate postoperative pain relief and chronic persistent postoperative pain. Anesthesiol Clin North America, 2005, 23(1): 21-36.
25.	Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth, 1997, 78(5): 606-617.
26.	Shang AB, Gan TJ. Optimising postoperative pain management in the ambulatory patient. Drugs, 2003, 63(9): 855-867.
27.	Woolf CJ, Chong MS. Preemptive analgesia--treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg, 1993, 77(2): 362-379.
28.	Pogatzki-Zahn EM, Zahn PK. From preemptive to preventive analgesia. Curr Opin Anaesthesiol, 2006, 19(5): 551-555.
29.	Melton MS, Nielsen KC, Tucker M, et al. New medications and techniques in ambulatory anesthesia. Anesthesiol Clin, 2014, 32(2): 463-485.
30.	Kehlet H, Dahl JB. The value of " multimodal” or " balanced analgesia” in postoperative pain treatment. Anesth Analg, 1993, 77(5): 1048-1056.
31.	Jakobsson JG. Pain management in ambulatory surgery-a review. Pharmaceuticals (Basel), 2014, 7(8): 850-865.
32.	Oderda GM, Gan TJ, Johnson BH, et al. Effect of opioid-related adverse events on outcomes in selected surgical patients. J Pain Palliat Care Pharmacother, 2013, 27(1): 62-70.
33.	Zeng Z, Lu J, Shu C, et al. A comparision of nalbuphine with morphine for analgesic effects and safety: meta-analysis of randomized controlled trials. Sci Rep, 2015, 5: 10927.
34.	Gunion MW, Marchionne AM, Anderson C. Use of the mixed agonist-antagonist nalbuphine in opioid based analgesia. Acute Pain, 2004, 6(1): 29-39.
35.	Parsons JD. The use of nalbuphine (nubain) and midazolam in sedation for dentistry. SAAD Dig, 1986, 6(6): 125-131.
36.	Bone ME, Dowson S, Smith G. A comparison of nalbuphine with fentanyl for postoperative pain relief following termination of pregnancy under day care anaesthesia. Anaesthesia, 1988, 43(3): 194-197.
37.	Salman OH. A controlled, double blind, study of adding Nalbuphine to Propofol for laryngeal mask insertion conditions and hemodynamics in adults. Egypt J Anaesth, 2015, 31(4): 277-281.
38.	Chin KW, Tan PK, Chin MK. Sedation for gastroscopy: a comparison between midazolam and midazolam with nalbuphine. Ann Acad Med Singapore, 1994, 23(3): 330-332.
39.	Fournier R, Van Gessel E, Macksay M, et al. Onset and offset of intrathecal morphine versus nalbuphine for postoperative pain relief after total hip replacement. Anesthesiology, 2000, 44(8): 940-945.
40.	Mukherjee A, Pal A, Agrawal J, et al. Intrathecal nalbuphine as an adjuvant to subarachnoid block: what is the most effective dose?. Anesth Essays Res, 2015, 5(2): 171-175.
41.	Liaqat N, Anwar K. Comparison of caudal block and nabuphine for pain management in children. JRMC, 2016, 20(1): 30-32.
42.	Madácsy L, Bertalan V, Szepes A, et al. Effect of nalbuphine on the motility of the sphincter of Oddi in patients with suspected sphincter of Oddi dysfunction. Gastrointest Endosc, 2003, 57(3): 319-323.
43.	Butsch JL, Okoli JA. The effect of nalbuphine on the common bile duct pressure. Am Surg, 1988, 54(5): 253-255.
44.	Vieira ZE, Zsigmond EK, Duarte B, et al. Double-blind comparison of butorphanol and nalbuphine on the common bile duct by ultrasonography in man. Int J Clin Pharmacol, 1993, 31(11): 564-567.

1. Miller RD, Cohen NH, Eriksson LI, et al. Miller’s anesthesia. 8th ed. Philadelphia: Elsevier Saunders, 2015: 1050-1051.
2. Beaver WT, Feise GA. A comparison of the analgesic effect of intramuscular nalbuphine and morphine in patients with postoperative pain. J Pharmacol Exp Ther, 1978, 204(2): 487-496.
3. Klepper ID, Rosen M, Vickers MD, et al. Respiratory function following nalbuphine and morphine in anaesthetized man. Br J Anaesth, 1986, 58(6): 625-629.
4. Parker RK, Holtmann B, White PF. Patient-controlled epidural analgesia: interactions between nalbuphine and hydromorphone. Anesth Analg, 1997, 84(4): 757-763.
5. Yeh YC, Lin TF, Lin FS, et al. Combination of opioid agonist and agonist-antagonist: patient-controlled analgesia requirement and adverse events among different-ratio morphine and nalbuphine admixtures for postoperative pain. Br J Anaesth, 2008, 101(4): 542-548.
6. Errick JK, Heel RC. Nalbuphine. A preliminary review of its pharmacological properties and therapeutic efficacy. Drugs, 1983, 26(3): 191-211.
7. Zola EM, Mcleod DC. Comparative effects and analgesic efficacy of the agonist-antagonist opioids. Drug Intell Clin Pharm, 1983, 17(6): 411-417.
8. Riviere PJ. Peripheral kappa-opioid agonists for visceral pain. Br J Pharmacol, 2004, 141(8): 1331-1334.
9. Narver HL. Nalbuphine, a non-controlled opioid analgesic, and its potential use in research mice. Lab Anim (NY), 2015, 44(3): 106-110.
10. Graham JL, McCaughey W, Bell PF. Nalbuphine and pentazocine in an opioid-benzodiazepine sedative technique: a double-blind comparison. Ann R Coll Surg Engl, 1988, 70(4): 200-204.
11. Sury MR, Cole PV. Nalbuphine combined with midazolam for outpatient sedation. An assessment of safety in volunteers. Anaesthesia, 1988, 43(4): 281-284.
12. Romagnoli A, Keats AS. Ceiling effect for respiratory depression by nalbuphine. Clin Pharmacol Ther, 1980, 27(4): 478-485.
13. Gal TJ, DiFazio CA, Moscicki J. Analgesic and respiratory depressant activity of nalbuphine: a comparison with morphine. Anesthesiology, 1982, 57(5): 367-374.
14. Bressolle F, Khier S, Rochette A, et al. Population pharmacokinetics of nalbuphine after surgery in children. Br J Anaesth, 2011, 106(4): 558-565.
15. Lee G, Low RI, Amsterdam EA, et al. Hemodynamic effects of morphine and nalbuphine in acute myocardial infarction. Clin Pharmacol Ther, 1981, 29(5): 576-581.
16. Lake CL, Duckworth EN, DiFazio CA, et al. Cardiovascular effects of nalbuphine in patients with coronary or valvular heart disease. Anesthesiology, 1982, 57(6): 498-503.
17. Zhang SZ, Wang NF, Xu J, et al. Kappa-opioid receptors mediate cardioprotection by remote preconditioning. Anesthesiology, 2006, 105(3): 550-556.
18. Zhang Y, Irwin MG, Wong TM, et al. Remifentanil preconditioning confers cardioprotection via cardiac kappa- and delta-opioid receptors. Anesthesiology, 2005, 102(2): 371-378.
19. Zsigmond EK, Winnie AP, Raza SM, et al. Nalbuphine as an analgesic component in balanced anesthesia for cardiac surgery. Anesth Analg, 1987, 66(11): 1155-1164.
20. Chawda PM, Pareek MK, Mehta KD. Effect of nalbuphine on haemodynamic response to orotracheal intubation. J Anaesthesiol Clin Pharmacol, 2010, 26(4): 458-460.
21. Fating DR, Dandekar AK, Tirpude NG. Role of IV nalbuphine in attenuation of haemodynamic response to laryngoscopy and endotracheal intubation. Indian J Clin Anaesth, 2016, 3(2): 165-169.
22. Gan TJ, Habib AS, Miller TE, et al. Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US National survey. Curr Med Res Opin, 2014, 30(1): 149-160.
23. Vanderah TW, Suenaga NM, Ossipov MH, et al. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci, 2001, 21(1): 279-286.
24. Joshi GP, Ogunnaike BO. Consequences of inadequate postoperative pain relief and chronic persistent postoperative pain. Anesthesiol Clin North America, 2005, 23(1): 21-36.
25. Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth, 1997, 78(5): 606-617.
26. Shang AB, Gan TJ. Optimising postoperative pain management in the ambulatory patient. Drugs, 2003, 63(9): 855-867.
27. Woolf CJ, Chong MS. Preemptive analgesia--treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg, 1993, 77(2): 362-379.
28. Pogatzki-Zahn EM, Zahn PK. From preemptive to preventive analgesia. Curr Opin Anaesthesiol, 2006, 19(5): 551-555.
29. Melton MS, Nielsen KC, Tucker M, et al. New medications and techniques in ambulatory anesthesia. Anesthesiol Clin, 2014, 32(2): 463-485.
30. Kehlet H, Dahl JB. The value of " multimodal” or " balanced analgesia” in postoperative pain treatment. Anesth Analg, 1993, 77(5): 1048-1056.
31. Jakobsson JG. Pain management in ambulatory surgery-a review. Pharmaceuticals (Basel), 2014, 7(8): 850-865.
32. Oderda GM, Gan TJ, Johnson BH, et al. Effect of opioid-related adverse events on outcomes in selected surgical patients. J Pain Palliat Care Pharmacother, 2013, 27(1): 62-70.
33. Zeng Z, Lu J, Shu C, et al. A comparision of nalbuphine with morphine for analgesic effects and safety: meta-analysis of randomized controlled trials. Sci Rep, 2015, 5: 10927.
34. Gunion MW, Marchionne AM, Anderson C. Use of the mixed agonist-antagonist nalbuphine in opioid based analgesia. Acute Pain, 2004, 6(1): 29-39.
35. Parsons JD. The use of nalbuphine (nubain) and midazolam in sedation for dentistry. SAAD Dig, 1986, 6(6): 125-131.
36. Bone ME, Dowson S, Smith G. A comparison of nalbuphine with fentanyl for postoperative pain relief following termination of pregnancy under day care anaesthesia. Anaesthesia, 1988, 43(3): 194-197.
37. Salman OH. A controlled, double blind, study of adding Nalbuphine to Propofol for laryngeal mask insertion conditions and hemodynamics in adults. Egypt J Anaesth, 2015, 31(4): 277-281.
38. Chin KW, Tan PK, Chin MK. Sedation for gastroscopy: a comparison between midazolam and midazolam with nalbuphine. Ann Acad Med Singapore, 1994, 23(3): 330-332.
39. Fournier R, Van Gessel E, Macksay M, et al. Onset and offset of intrathecal morphine versus nalbuphine for postoperative pain relief after total hip replacement. Anesthesiology, 2000, 44(8): 940-945.
40. Mukherjee A, Pal A, Agrawal J, et al. Intrathecal nalbuphine as an adjuvant to subarachnoid block: what is the most effective dose?. Anesth Essays Res, 2015, 5(2): 171-175.
41. Liaqat N, Anwar K. Comparison of caudal block and nabuphine for pain management in children. JRMC, 2016, 20(1): 30-32.
42. Madácsy L, Bertalan V, Szepes A, et al. Effect of nalbuphine on the motility of the sphincter of Oddi in patients with suspected sphincter of Oddi dysfunction. Gastrointest Endosc, 2003, 57(3): 319-323.
43. Butsch JL, Okoli JA. The effect of nalbuphine on the common bile duct pressure. Am Surg, 1988, 54(5): 253-255.
44. Vieira ZE, Zsigmond EK, Duarte B, et al. Double-blind comparison of butorphanol and nalbuphine on the common bile duct by ultrasonography in man. Int J Clin Pharmacol, 1993, 31(11): 564-567.

Previous Article
術后認知功能障礙外周血循環生物標志物概述
Next Article
正常血糖-高胰島素鉗夾技術在胰島素制劑藥物代謝動力學研究中的應用進展

West China Medical Journal

納布啡在日間手術預防性多模式鎮痛中的優勢

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content